Over the last 12 months, Vertex Pharmaceuticals Inc / Ma insiders reported no purchases and 9 sales totaling $6.6M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Tatsis OuraniaEVP, Chief Reg. & Quality Off. · O | ▼ Sale | 1,500 | $524.99 | $787K | -3.2% | plan |
| Jul 2, 2026 | McKechnie DuncanEVP, Chief Commercial Officer · O | ▼ Sale | 1,541 | $519 | $800K | -12.3% | plan |
| Jul 1, 2026 | Liu JoyEVP and Chief Legal Officer · O | ▼ Sale | 828 | $502.71 | $416K | -4.1% | plan |
| Jun 26, 2026 | Bozic CarmenEVP and CMO · O | ▼ Sale | 596 | $482.5 | $288K | -3.7% | plan |
| Jun 18, 2026 | Bozic CarmenEVP and CMO · O | ▼ Sale | 1,020 | $462.17 | $471K | -6% | plan |
| Jun 15, 2026 | Bozic CarmenEVP and CMO · O | ▼ Sale | 4,062 | $450 | $1.8M | -19.3% | plan |
| Jun 5, 2026 | Bozic CarmenEVP and CMO · O | ▼ Sale | 1,745 | $450 | $785K | -7.7% | plan |
| Jun 1, 2026 | Liu JoyEVP and Chief Legal Officer · O | ▼ Sale | 828 | $439.91 | $364K | -4% | plan |
| May 29, 2026 | Bozic CarmenEVP and CMO · O | ▼ Sale | 1,974 | $450 | $888K | -8% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $VRTX feed.